SPOTLIGHT -
Are Migraines and PTSD Linked?
Genes may hold the answer to the puzzling comorbidity of migraines and posttraumatic stress disorder.
Prime Day Deals for Mental Health
These deals can help boost you and your patients’ mental health.
First in Class Therapeutic for MDD Shows Promising Results
Zuranolone showed statistically significant improvement in depressive symptoms in this latest study.
Poetry for PTSD and Preventing Suicide
This renowned psychiatrist is donating a portion of the proceeds from his book sales to help stop US military veteran suicides.
A Bill to End the War on Drugs
The Drug Policy Reform Act, introduced today, intends to decriminalize drug use and possession, providing health-centered approaches and rehabilitation instead.
Children’s Mental Health Response to COVID-19
What impact has the pandemic had on children's mental health?
Vaccinated Physicians
Have you gotten your COVID-19 vaccine?
Liftoff! Brain Monitoring Startup Bound for Space
This is a rare opportunity for researchers and entrepreneurs from a variety of fields to conduct experiments in space.
PTSD by the Numbers
June is posttraumatic stress disorder (PTSD) Awareness Month!
First New Treatment Approved for Alzheimer Disease in Nearly 2 Decades
This one-of-a-kind Alzheimer disease treatment targets the amyloid beta plaques in the brain, potentially slowing cognitive decline.
FDA Approves a New Atypical Antipsychotic With Less Adverse Effects
This combination treatment of olanzapine and samidorphan caused significantly less weight gain in patients with schizophrenia and bipolar I disorder.
What Is an SGM Community?
What terms are used to describe SGM and LGBTQ+ identities?
Going Maskless
Over a third of older Americans aren't comfortable taking off their masks until 2022.
Drug for the Treatment of Agitation Moves Closer to Reality
This treatment for agitation associated with schizophrenia and bipolar disorder is moving up the FDA ladder…
Posters Indicate Potential Benefit for Patients With Schizophrenia
Two posters presented at the APA virtual meeting demonstrated long-acting injectable positive results, costs savings, and increased telehealth for patients with schizophrenia.
Multitude of Selves: Applying to Residencies as an LGBTQ+ Medical Student
Finding a program that is a good fit while LGBTQ+ may be more difficult than it seems…
The Tip of the Iceberg for Women in Academic Psychiatry
Young, professional women in academic psychiatry are facing down the iceberg: gender discrimination.
A Tale of Two Crises: Fighting the Overdose Problem During the Pandemic
According to Nora D. Volkow, MD, Director of the National Institute on Drug Abuse, drug use and overdose deaths have significantly increased since the outset of the pandemic. What made it worse?
Late-Stage Pipeline Candidate Looks Promising for the Treatment of Schizophrenia
Data presented at the 2021 APA Virtual Annual Meeting show promise for treating schizophrenia.
Depression: A Family Affair
Can depression be passed on to future generations, and if it can, how can treatment help?
Ketamine: Not A Simple Treatment, But a Worthy One
One doctor at the APA Virtual meeting explains how ketamine can rebuild spine and synaptic proteins in the brain, but may be difficult to actually prescribe to patients.
Addressing the Opioid Crisis: A New Approval
The FDA approved a higher dose of naloxone to treat opioid overdose deaths.
Samidorphan: Scheduled Substance No More
The Drug Enforcement Administration has freed this formerly schedule II controlled substance.
Clearing the Smoke: FDA Working Toward Tobacco Flavor Ban to Save Lives, Promote Health Equity
Looking to reduce youth initiation into tobacco products, the FDA takes steps against menthol cigarettes and flavored cigars.
Treating Depression in 3 Minutes
The FDA cleared the way to use this deep transcranial magnetic stimulation system, which may be able to help treat depression in less than 5 minutes.
Real-World Effectiveness: New MDD Treatment
A recent study evaluated the everyday efficacy of this novel treatment for major depressive disorder.
Extended-Release Risperidone Capsule Making Waves
A new risperidone capsule for the treatment of schizophrenia sees positive phase 2 study results.
7 States Improving Employment Outcomes for Individuals With Mental Health Conditions
These states will receive funding to increase competitive integrated employment for patients with mental health conditions.
Visual Perception Affected by Depression
Patients with depression may have altered cortical processing of visual contrast during a major depressive episode.
Digital Therapeutics Improves Paranoia
While this digital therapy failed to meet its primary endpoint in a recent clinical trial, results suggest it may improve paranoia in general.